Cáncer de ovario avanzado y linfadenectomía
Ortiz Quintana, Luis.
Prog. obstet. ginecol. (Ed. impr.)
; 62(2): 103-106, mar.-abr. 2019.
Artículo en Español | IBECS (España) | ID: ibc-184902
Documentos relacionados
Systematic lymphadenectomy and interval debulking surgery: less is more.
Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection.
Response to: Correspondence on 'The Cukurova score in the prediction of primary cytoreduction in ovarian cancer' by Verit et al.
Correspondence on 'The Cukurova score in the prediction of primary cytoreduction in ovarian cancer' by Khatib et al.
Nomogram to predict feasibility of minimally invasive interval debulking surgery in advanced ovarian cancer.
Splenectomy as a part of cytoreductive surgery in ovarian cancer: systematic review and meta-analysis.
Cytoreduction of bulky para-aortic lymphadenopathy from metastatic ovarian cancer.
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study.
ASO Author Reflections: Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery.
Secondary cytoreduction in ovarian cancer: who really benefits?